CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Summary
A Phase 2 trial of CM310 injection for moderate-to-severe atopic dermatitis has completed; the update summarizes the study status and outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED